JP3342065B2 - Agglutination reaction method and agglutination reaction device, and concentration measurement method and concentration measurement device - Google Patents
Agglutination reaction method and agglutination reaction device, and concentration measurement method and concentration measurement deviceInfo
- Publication number
- JP3342065B2 JP3342065B2 JP33490592A JP33490592A JP3342065B2 JP 3342065 B2 JP3342065 B2 JP 3342065B2 JP 33490592 A JP33490592 A JP 33490592A JP 33490592 A JP33490592 A JP 33490592A JP 3342065 B2 JP3342065 B2 JP 3342065B2
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- substance
- electrode
- agglutination reaction
- agglutination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は、試料液中の物質と、作
用物質、特に前記試料液中の微量物質と選択特異的に結
合する生体関連物質とを凝集反応させる方法及び装置、
更には、それらを用いて試料液中の物質の濃度を測定す
る方法及び装置に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method and an apparatus for agglutinating a substance in a sample liquid with an active substance, in particular, a biological substance which selectively binds to a trace substance in the sample liquid.
Furthermore, the present invention relates to a method and an apparatus for measuring the concentration of a substance in a sample liquid by using them.
【0002】[0002]
【従来の技術】従来より、試料液中の物質と、生体関連
物質との作用により凝集反応をさせ、その凝集の度合を
測定して前記試料液中の物質、例えば免疫的に活性な抗
原の濃度を測定する方法がある。2. Description of the Related Art Conventionally, an agglutination reaction is caused by the action of a substance in a sample liquid and a biological substance, and the degree of the aggregation is measured to determine the degree of aggregation of the substance, for example, an immunologically active antigen. There is a method of measuring the concentration.
【0003】このような方法としては、抗原と選択特異
的に結合する抗体を担持したポリスチレン等の微粒子
を、水などの液体媒体中に分散させた分散液(ラテック
ス試薬)に、上記の免疫的に活性な抗原を有する試料液
を作用させることにより起こる凝集を観察して、試料液
中の抗原の濃度測定を行うラテックス凝集イムノアッセ
イ法(LAIA)があり、ジェー・エム・シンガーら
(J.M.Singeret.al.)により見い出さ
れ[Am.J.Med.,21888(1956)参
照]、その後、該方法について様々な検討がなされてい
る。そして、その凝集の度合を判定する方法としては、
定量的な測定は困難ではあるが、簡便でかつ結果が短時
間に得られるという利点があることから、視覚による判
定方法が実用上広く普及している。As such a method, the above-mentioned immunological method is applied to a dispersion liquid (latex reagent) in which fine particles such as polystyrene carrying an antibody that selectively binds to an antigen are dispersed in a liquid medium such as water. Latex agglutination immunoassay (LAIA) for measuring the concentration of antigen in a sample solution by observing the agglutination caused by the action of a sample solution having an active antigen on the surface of the sample solution is described in JM Singer et al. Singeret. Al.) [Am. J. Med. , 21888 (1956)], and thereafter, various studies have been made on the method. And, as a method of determining the degree of the aggregation,
Although quantitative measurement is difficult, there is an advantage that the result is simple and the result can be obtained in a short time. Therefore, a visual judgment method is widely used practically.
【0004】近年になって、凝集の度合を光学的に測定
する試みがなされ、エー・フェーチュアら(A.Fat
ure et.al.)は、凝集反応に伴う濁度の変化
を光学的に測定、動力学的解析から定量分析を行う方法
を提案している[A.Fature et.al.;P
rotides Biol Fluids,Proc.
Colloq.,2589(1972)]。[0004] In recent years, attempts have been made to optically measure the degree of agglomeration.
ure et. al. ) Proposes a method of optically measuring the change in turbidity due to the agglutination reaction and performing quantitative analysis from kinetic analysis [A. Feature et. al. ; P
rotides Biol Fluids, Proc.
Colloq. , 2589 (1972)].
【0005】このような凝集反応を利用した検査では、
ラテックス試薬と試料液とを混合後、静置して、その凝
集の度合を測定する方法が行なわれていた。In an inspection utilizing such an agglutination reaction,
A method has been performed in which a latex reagent and a sample solution are mixed, left to stand, and the degree of aggregation is measured.
【0006】[0006]
【発明が解決しようとする課題】しかしながら、このよ
うな試薬と試料液とを混合後、静置する方法では、ラテ
ックス試薬の自然拡散にのみその反応速度が依存してし
まうので、短時間での測定が難しかったり、測定データ
が不正確であったりするという問題があった。However, in such a method in which the reagent and the sample solution are mixed and allowed to stand, the reaction rate depends only on the natural diffusion of the latex reagent, so that the reaction time is short. There are problems that measurement is difficult and measurement data is inaccurate.
【0007】そこで、これらの凝集反応を利用した手法
では、短時間の検査の必要性から、前述した液体媒体中
での微量物質と生体関連物質との凝集反応を行う際に、
液体媒体を攪拌して反応を促進することが行なわれる。[0007] Therefore, in the method utilizing these agglutination reactions, the necessity of a short-time inspection is required to carry out the agglutination reaction between a trace substance and a biological substance in a liquid medium as described above.
Agitation of the liquid medium is performed to promote the reaction.
【0008】従来、この液体媒体の攪拌には、攪拌子に
よる力学的攪拌や振動を与えるといった手法を用いてい
る。Conventionally, a method of mechanically agitating or applying vibrations by a stirrer has been used for stirring the liquid medium.
【0009】しかしながら、これらの手法では多量の液
体媒体や試薬や試料液を必要としたり、装置自体が大き
いといった問題があった。However, these methods have problems that a large amount of liquid medium, reagents and sample liquids are required, and that the apparatus itself is large.
【0010】上記従来技術の問題点に鑑み、本発明の目
的とするところは、より短時間で、しかも少量の液体
(分散媒、試料液等)を用いて簡単に凝集反応を行う方
法及び装置、更には、試料液中の物質の濃度を測定する
方法及び装置を提供することにある。In view of the above problems of the prior art, an object of the present invention is to provide a method and an apparatus for easily performing an agglutination reaction in a shorter time and using a small amount of liquid (dispersion medium, sample liquid, etc.). Another object of the present invention is to provide a method and an apparatus for measuring the concentration of a substance in a sample solution.
【0011】[0011]
【課題を解決するための手段及び作用】上記目的を達成
するために成された本発明は、試料液中の物質と、該物
質と選択特異的に結合する生体関連物質とを、イオン導
電性を有する液体媒体中で凝集反応させる方法であっ
て、電極対の間に上記試料液と上記生体関連物質とを分
散させたイオン導電性を有する液体媒体を導入し、上記
電極対間に正側と負側に周期的に変動する交番電圧を印
加して、上記液体媒体を攪拌することを特徴とする凝集
反応方法であり、また、この凝集反応方法を実施する装
置であって、前記電極対を少なくとも1組以上設けた反
応セルと、該電極対間に正側と負側に周期的に変動する
交番電圧を印加する電源手段を具備することを特徴とす
る凝集反応装置である。SUMMARY OF THE INVENTION The present invention, which has been made to achieve the above object, provides a method for converting a substance in a sample solution and a biological substance which selectively binds to the substance into an ionic conductive material. A method for causing an agglutination reaction in a liquid medium having a liquid medium having an ion conductivity in which the sample liquid and the biological substance are dispersed between an electrode pair, and a positive side is provided between the electrode pair. And applying an alternating voltage that periodically fluctuates to the negative side to agitate the liquid medium, and an apparatus for performing the agglutination reaction method, wherein the electrode pair And a reaction cell provided with at least one set of the electrode, and periodically fluctuates between the electrode pair between the positive side and the negative side.
An agglutination reaction device comprising power supply means for applying an alternating voltage.
【0012】更にはまた、本発明は、上記凝集反応方法
により生ずる反応混合物の凝集の度合を検出して、前記
試料液中の物質の濃度を測定することを特徴とする濃度
測定方法であり、また、この濃度測定方法を実施する装
置であって、前記電極対を少なくとも1組以上設けた反
応セルと、該電極対間に正側と負側に周期的に変動する
交番電圧を印加する電源手段と、上記反応セル内の反応
混合物の凝集の度合を検出する検出手段を具備すること
を特徴とする濃度測定装置である。Furthermore, the present invention is a concentration measuring method characterized by detecting a degree of agglutination of a reaction mixture generated by the agglutination reaction method and measuring a concentration of a substance in the sample solution, Further, there is provided an apparatus for carrying out the concentration measuring method, wherein a reaction cell provided with at least one or more pairs of the electrodes is periodically changed between a positive side and a negative side between the electrode pairs.
A concentration measuring device comprising: a power supply unit for applying an alternating voltage; and a detection unit for detecting the degree of aggregation of the reaction mixture in the reaction cell.
【0013】本発明で用いることのできる前記試料液中
の物質及び生体関連物質としては、相互に選択特異的に
結合する物質であれば特に限定されるものではない。The substance in the sample solution and the biological substance that can be used in the present invention are not particularly limited as long as they are substances that selectively bind to each other.
【0014】上記試料液中の物質としては、例えば生体
内の物質では、蛋白質、糖、ホルモン、ウイルス、DN
A、RNA等が挙げられる。Examples of the substance in the sample liquid include proteins, sugars, hormones, viruses, DN,
A, RNA and the like.
【0015】一方、試薬としての上記生体関連物質は、
上記の物質に対して生物学的特異性を示すものを選択す
ることができる。On the other hand, the above-mentioned biological substance as a reagent is
Those exhibiting biological specificity for the above substances can be selected.
【0016】ここで、生物学的特異性とは、例えば抗原
−抗体反応や、DNA、RNAのハイブリダイゼーショ
ンやアビジン−ビオチン結合等の特異的結合が形成され
ることを意味する。Here, the term "biological specificity" means that a specific bond such as an antigen-antibody reaction, DNA and RNA hybridization, and avidin-biotin bond is formed.
【0017】本発明で言う生体関連物質とは、天然もし
くは合成のペプチド、蛋白質、酵素、糖類、レクチン、
ウイルス、細菌、核酸、DNA、RNA、抗原(例えば
リコンビナント抗原も含む)抗体などを含む。また臨床
病理的に特に有用な物質としては、以下のものが挙げら
れる。The biological substances referred to in the present invention include natural or synthetic peptides, proteins, enzymes, saccharides, lectins,
Includes viruses, bacteria, nucleic acids, DNA, RNA, antigens (including, for example, recombinant antigens) and antibodies. The following substances are particularly useful in clinicopathology.
【0018】IgG,IgM,IgEなどの免疫グロブ
リン、補体,CRP,フェリチン,α1 マイクログロブ
リン,β2 マイクログロブリンなどの血漿蛋白およびそ
れらの抗体、α−フェトプロテイン,癌胎児性抗原(C
EA),前立腺性酸性ホスファターゼ(PAP),CA
19−9,CA−125などの腫瘍マーカおよびそれら
の抗体、黄体化ホルモン(LH),卵胞刺激ホルモン
(FSH),ヒト繊毛性ゴナドトロビン(hCG),エ
ストロゲン,インスリンなどのホルモン類およびそれら
の抗体、HBV関連抗原(HBs.HBe.HBc),
HIV,ATLなどウイルス感染関連物質およびそれら
の抗体、ジフテリア菌,ボツリヌス菌,マイコプラズ
マ,梅毒トレポネーマなどのバクテリア類およびそれら
の抗体、トキソプラズマ,トリコモナス,リーシュマニ
ア,トリバノゾーマ,マラリア原虫などの原虫類および
それらの抗体、フェニトイン,フェノバルビタールなど
の抗てんかん薬、キニジン,ジゴキシニンなどの心血管
薬、テオフィリンなどの抗喘息薬、クロラムフェニコー
ル,ゲンタマイシンなどの抗生物質などの薬物類および
それらの抗体、その他酵素,菌体外毒素(スチレリジン
Oなど)およびそれらの抗体などがあり、上記の試料液
中の物質と抗原−抗体反応等を起こす物質が適宜選択さ
れて使用される。[0018] IgG, IgM, immunoglobulin, such as IgE, complement, CRP, ferritin, alpha 1-microglobulin, plasma proteins and their antibodies such as beta 2-microglobulin, alpha-fetoprotein, carcinoembryonic antigen (C
EA), prostatic acid phosphatase (PAP), CA
Tumor markers such as 19-9, CA-125 and their antibodies, luteinizing hormone (LH), follicle stimulating hormone (FSH), human ciliary gonadotrobin (hCG), hormones such as estrogen, insulin and their antibodies; HBV-related antigen (HBs. HBe. HBc),
Virus infection related substances such as HIV and ATL and their antibodies, bacteria such as diphtheria, botulinum, mycoplasma, treponema pallidum and their antibodies, protozoa such as toxoplasma, trichomonas, leishmania, trivanozoma, malaria parasite, and the like Antiepileptic drugs such as antibodies, phenytoin, phenobarbital, cardiovascular drugs such as quinidine and digoxinine, antiasthmatic drugs such as theophylline, antibiotics such as chloramphenicol and gentamicin, and drugs such as antibodies and other enzymes, There are bacterial exotoxins (such as styrrelidine O) and antibodies thereof, and a substance that causes an antigen-antibody reaction with the substance in the sample solution is appropriately selected and used.
【0019】一般に、上記抗原−抗体反応等では、試料
液中の物質と試薬としての生体関連物質とが凝集反応を
する。この際、この物質の種類や量によっては、生体関
連物質を微粒子表面上に担持させて凝集反応をさせるこ
とができる。In general, in the antigen-antibody reaction or the like, a substance in a sample solution and a biological substance as a reagent undergo an agglutination reaction. At this time, depending on the type and amount of the substance, a bio-related substance can be carried on the fine particle surface to cause an agglutination reaction.
【0020】本発明に用いられる上記微粒子としては、
生物に由来する微粒子、無機系微粒子、有機系微粒子を
挙げることができる。前記生物に由来する微粒子として
は、例えば、赤血球、分散処理されたブドウ球菌、連鎖
球菌等の細菌類等が挙げられる。前記無機系微粒子とし
ては、例えば、シリカ、アルミナ、ベントナイト等が挙
げられる。また、前記有機系微粒子としては、例えば、
スチレン、塩化ビニル、アクリロニトリル、酢酸ビニ
ル、アクリル酸エステル類、メタクリル酸エステル類な
どのビニル系モノマーの単一重合体および/又はそれら
の共重合体、スチレン−ブタジエン共重合体、メチルメ
タクリレート−ブタジエン共重合体などのブタジエン系
共重合体、脂質二分子膜のリポソームなどの微粒子が挙
げられる。The fine particles used in the present invention include:
Examples of the fine particles include biological fine particles, inorganic fine particles, and organic fine particles. Examples of the microparticles derived from the organism include bacteria such as erythrocytes, dispersed staphylococci, and streptococci. Examples of the inorganic fine particles include silica, alumina, bentonite and the like. Further, as the organic fine particles, for example,
Homopolymers and / or copolymers of vinyl monomers such as styrene, vinyl chloride, acrylonitrile, vinyl acetate, acrylates and methacrylates, styrene-butadiene copolymer, methyl methacrylate-butadiene copolymer Examples include butadiene-based copolymers such as coalesced particles and fine particles such as lipid bilayer liposomes.
【0021】こうした微粒子への生体関連物質の結合
は、後述するように、物理的および/又は化学的になさ
れるが、その中で物理的結合は微粒子表面が疎水性であ
ることが好ましく、スチレン単一重合体微粒子、スチレ
ンを主成分とするビニル系共重合体微粒子又はスチレン
を主成分とするスチレン−ブタジエン共重合体が特に好
ましい。上述の微粒子の粒子径は、生物に由来する微粒
子、無機系微粒子、有機系微粒子のいずれの場合にあっ
ても、0.05μm乃至10μmの範囲が好ましく、特
に好ましくは0.2μm乃至5μmの範囲である。上記
粒子径が0.05μmを下回ると、試薬としての生体関
連物質をその表面に分散することが困難になり、又10
μmを上回ると分散された試薬の安定性が不良になる。The binding of the bio-related substance to the fine particles is performed physically and / or chemically as described later. In the physical bonding, the surface of the fine particles is preferably hydrophobic, and styrene is preferably used. Particularly preferred are homopolymer fine particles, vinyl copolymer fine particles containing styrene as a main component, or styrene-butadiene copolymer containing styrene as a main component. The particle size of the above-mentioned fine particles is preferably in the range of 0.05 μm to 10 μm, particularly preferably in the range of 0.2 μm to 5 μm, in any case of fine particles derived from living organisms, inorganic fine particles, and organic fine particles. It is. When the particle diameter is less than 0.05 μm, it becomes difficult to disperse a biological substance as a reagent on the surface thereof, and
Above μm, the stability of the dispersed reagent becomes poor.
【0022】また、本発明において、上記微粒子の表面
に前述の生体関連物質を担持(固定化)させるには、以
下の公知の方法が利用できる。In the present invention, the following known method can be used to carry (immobilize) the above-mentioned biological substance on the surface of the fine particles.
【0023】例えば、i)イオン結合法、ii)物理吸
着法、iii)共有結合法などが挙げられる。For example, i) an ion bonding method, ii) a physical adsorption method, and iii) a covalent bonding method.
【0024】イオン結合法は、蛋白質、DNA、RNA
等の生体関連物質を微粒子表面に静電的に結合させるも
のである。The ion binding method is used for proteins, DNA, RNA
And the like, such that biologically-related substances such as are electrostatically bound to the surface of the fine particles.
【0025】物理吸着法は、微粒子表面の親油性部と蛋
白質の親油性部との疎水結合を利用する結合法である。The physical adsorption method is a bonding method utilizing a hydrophobic bond between a lipophilic portion on the surface of fine particles and a lipophilic portion of a protein.
【0026】イオン結合法、および物理吸着法において
は結合反応工程は簡単であるが、微粒子と生体関連物質
との結合力が弱い。In the ion bonding method and the physical adsorption method, the bonding reaction step is simple, but the bonding force between the fine particles and the biological substance is weak.
【0027】一方、共有結合法は、微粒子表面又は生体
関連物質の少なくとも一方に反応性の高い官能基を結合
し、これを介して両者を共有結合するものであり、強固
な結合力が得られる。共有結合法により微粒子と生体関
連物質とを結合させる際に、生体関連物質中の結合に関
与できる官能基としては、遊離のアミノ基、水酸基、リ
ン酸基、カルボキシル基、システインのスルフヒドリル
基、ヒスチジンのイミダゾール基、チロシンのフェノー
ル基、セリン,トレオニンの水酸基などがある。On the other hand, in the covalent bonding method, a highly reactive functional group is bonded to at least one of the fine particle surface and the biological substance, and the two are covalently bonded via the functional group, and a strong bonding force can be obtained. . When the microparticles and the biological substance are bound by the covalent bonding method, the functional groups that can participate in the binding in the biological substance include free amino groups, hydroxyl groups, phosphate groups, carboxyl groups, cysteine sulfhydryl groups, and histidine. Imidazole group, tyrosine phenol group, serine and threonine hydroxyl group.
【0028】これらの官能基は、種々のジアゾニウム
塩、酸アミド、イソシアナート、活性型のハロゲン化ア
ルキル基、活性型のエステル基などと反応する。従っ
て、これらの官能基を微粒子表面に導入することによ
り、種々の方法で微粒子表面に生体関連物質を担持でき
る。一方、生体関連物質、特に蛋白質を含む生体関連物
質の高次構造は、水素結合、疎水結合、イオン結合など
の比較的弱い結合によって保持されているため壊れ易
く、従って固定化に際しては、高温、強酸、強アルカリ
などの処理を避けて、緩和な条件下に行なうことが望ま
しい。These functional groups react with various diazonium salts, acid amides, isocyanates, active alkyl halide groups, active ester groups, and the like. Therefore, by introducing these functional groups onto the surface of the fine particles, a bio-related substance can be supported on the surface of the fine particles by various methods. On the other hand, higher-order structures of biological substances, particularly biological substances including proteins, are fragile because they are held by relatively weak bonds such as hydrogen bonds, hydrophobic bonds, and ionic bonds. It is desirable to carry out the treatment under mild conditions, avoiding treatments such as strong acids and strong alkalis.
【0029】緩和な条件下に固定化反応を行う1つの方
法として、微粒子と生体関連物質の官能基とに反応する
二官能性の架橋剤を使用することができる。二官能性の
架橋剤としては例えば、一般式R−N=C=N−R’で
表わされるカルボジイミド、一般式CHO−R−CHO
で表わされるジアルデヒド、O=C=N−R−N=C=
Oで表わされるジイソシアネート等がある(これらの一
般式中、R,R’は同一、又は異なる置換、または未置
換のアルキル基、アリール基、アルキルアリール基又
は、アリールアルキル基である)。As one method for carrying out the immobilization reaction under mild conditions, a bifunctional crosslinking agent which reacts with the fine particles and the functional group of the biological substance can be used. Examples of the bifunctional crosslinking agent include carbodiimides represented by the general formula RN = C = NR 'and general formulas CHO-R-CHO
A dialdehyde represented by the formula: O = C = NRN = C =
And diisocyanates represented by O (in these general formulas, R and R 'are the same or different and substituted or unsubstituted alkyl, aryl, alkylaryl or arylalkyl groups).
【0030】本発明では、前記被測定物質を含む試料液
と、前記試薬としての生体関連物質あるいはこれを担持
している前記微粒子は、イオン導電性を有する液体媒体
中に分散される。In the present invention, the sample liquid containing the substance to be measured and the biological substance as the reagent or the fine particles carrying the substance are dispersed in a liquid medium having ionic conductivity.
【0031】上記イオン導電性を有する液体媒体として
は、電解質を溶解させた水又は水およびアルコール類,
ケトン類などの水と相溶性のある有機溶媒との混合溶媒
が使用される。これらの液体中で電解質の一部又はすべ
てが電離してイオンとなっていることがイオン導電性の
ためには必要である。また、液体媒体には適宜pH緩衝
剤、蛋白質、界面活性剤、水溶性高分子化合物などが添
加される。Examples of the liquid medium having ionic conductivity include water in which an electrolyte is dissolved or water and alcohols;
A mixed solvent of an organic solvent compatible with water such as ketones is used. It is necessary for the ionic conductivity that part or all of the electrolyte in these liquids be ionized to ions. Further, a pH buffer, a protein, a surfactant, a water-soluble polymer compound and the like are appropriately added to the liquid medium.
【0032】一般に、抗原−抗体反応やハイブリダイゼ
ーションは、溶媒のpHの影響を受けやすいので、最適
のpHに調節するためにpH緩衝剤が添加される。例え
ば、リン酸塩やTris、HCl緩衝剤などが使用され
る。蛋白質は、非特異反応を防止する目的で添加され、
例えば牛血清アルブミン、ゼラチンなどが使用される。
界面活性剤、水溶性高分子化合物は、試薬の分散助剤と
して有効であり、例えばトウイーン20などの非イオン
界面活性剤やアニオン系界面活性剤、ポリビニルアルコ
ール、ポリアクリルアミド、ポリアクリル酸塩、ヒドロ
キシエチルセルロースなどが用いられる。しかし、これ
らの添加物は凝集反応を阻害しない範囲で使用される。Generally, the antigen-antibody reaction and the hybridization are easily affected by the pH of the solvent, and thus a pH buffer is added to adjust the pH to an optimum value. For example, phosphate, Tris, HCl buffer and the like are used. Protein is added to prevent non-specific reactions,
For example, bovine serum albumin, gelatin and the like are used.
Surfactants and water-soluble polymer compounds are effective as a dispersing aid for reagents. For example, nonionic surfactants such as Tween 20 and anionic surfactants, polyvinyl alcohol, polyacrylamide, polyacrylate, hydroxyacrylate, etc. Ethyl cellulose or the like is used. However, these additives are used in a range that does not inhibit the agglutination reaction.
【0033】また、上記液体媒体により前記試薬は試料
液中の物質の種類や量によって適宜、希釈調整される。
その固形分濃度は使用する反応セル等の種類またはサイ
ズにより異なるが、一般的には好ましくは、0.01〜
5%、より好ましくは0.05〜2%の範囲で調整され
る。Further, the reagent is appropriately diluted and adjusted by the liquid medium according to the kind and amount of the substance in the sample solution.
The solid concentration varies depending on the type or size of the reaction cell or the like to be used, but is generally preferably from 0.01 to
It is adjusted in 5%, more preferably in the range of 0.05 to 2%.
【0034】本発明では、前記被測定物質を含む試料液
と、前記試薬を分散したイオン導電性を有する液体媒体
を電極対の間に導入し、この電極対間に周期的に変動す
る電圧を印加して、電極近傍のイオンに電磁気力を作用
させ、液体媒体を撹拌している。In the present invention, a sample liquid containing the substance to be measured and a liquid medium having ionic conductivity in which the reagent is dispersed are introduced between the electrode pairs, and a voltage that fluctuates periodically between the electrode pairs is applied. The liquid medium is agitated by applying an electromagnetic force to the ions in the vicinity of the electrodes.
【0035】このため、イオン導電性を有する液体媒体
の導電率は大きい方が望ましく、好ましい範囲としては
10-5S/cm以上、さらに好ましくは10-4S/cm
以上である。この導電率が小さいと、電極対の間に流れ
る電流が小さくなり、また同時に電極近傍に生じる磁界
も小さくなるため、イオンに作用する電磁気力が小さく
なり液体媒体の流動が難しくなる。For this reason, the conductivity of the liquid medium having ionic conductivity is desirably large, and is preferably in the range of 10 −5 S / cm or more, more preferably 10 −4 S / cm or more.
That is all. When the electric conductivity is small, the current flowing between the electrode pair decreases, and at the same time, the magnetic field generated in the vicinity of the electrode decreases, so that the electromagnetic force acting on the ions decreases and the flow of the liquid medium becomes difficult.
【0036】本発明に用いられる電極としては、金属,
カーボン等、従来公知の電極材料やこれらを導電性フィ
ラーとして分散させた高分子材料やポリピロール等の導
電性高分子材料等が使用可能である。一般にこれら電極
材料の選択は、電極対間に印加する電圧によって異な
る。すなわち、印加電圧に直流(DC)成分が存在する
と、電極材料によっては陽極酸化を受け、電極の溶解や
酸化被膜の形成が起こり、液体媒体の流動やその耐久安
定性に悪影響を及ぼす場合がある。このような場合、白
金等の陽極酸化を受けにくい電極材料を選択する必要が
ある。また、印加電圧を下げることも考えられるが、イ
オンに作用する電磁気力が低く制限されるため、液体媒
体の流動スピードの上限が低く抑えられたり、流動でき
ない可能性もある。The electrodes used in the present invention include metals,
Conventionally known electrode materials such as carbon, polymer materials in which these are dispersed as conductive fillers, and conductive polymer materials such as polypyrrole can be used. Generally, the choice of these electrode materials depends on the voltage applied between the electrode pairs. That is, if a direct current (DC) component is present in the applied voltage, depending on the electrode material, anodization occurs, and the electrode is dissolved or an oxide film is formed, which may adversely affect the flow of the liquid medium and its durability stability. . In such a case, it is necessary to select an electrode material such as platinum that is not easily subjected to anodic oxidation. Although it is conceivable to lower the applied voltage, the electromagnetic force acting on the ions is limited to a low value, so that the upper limit of the flow speed of the liquid medium may be suppressed low or the liquid medium may not flow.
【0037】これらの点を考慮すると、電極対間に印加
する電圧としては、周期的に変動する電圧が好ましい。
この場合、その波形には特に制限はなく、矩形波、正弦
波、三角波等を用いることができる。In consideration of these points, the voltage applied between the electrode pairs is preferably a periodically fluctuating voltage.
In this case, the waveform is not particularly limited, and a rectangular wave, a sine wave, a triangular wave, or the like can be used.
【0038】周期的に変動する電圧としては、例えば図
5(a)に示すような交番(AC)電圧がある。交番電
圧は、印加電圧の時間平均が0であるので、電極の陽極
酸化や液体の電気分解が生じにくいので特に好ましい。As the voltage which fluctuates periodically, for example, there is an alternating (AC) voltage as shown in FIG. Since the time average of the applied voltage is 0, the alternating voltage is particularly preferable because the anodic oxidation of the electrode and the electrolysis of the liquid hardly occur.
【0039】必要に応じては、複数の交番電圧を合成し
た電圧でも良いし、図5(b)のような交番電圧に直流
電圧を重ねた電圧でもよいが、この際の直流電圧値は、
前述の陽極酸化等が生じない範囲である必要がある。If necessary, a voltage obtained by combining a plurality of alternating voltages or a voltage obtained by superimposing a DC voltage on an alternating voltage as shown in FIG. 5B may be used.
It is necessary that the thickness be in a range where the above-described anodic oxidation does not occur.
【0040】また、図5(c)に示した矩形波電圧のよ
うにDuty比が変えられる印加電圧の場合、好ましい
Duty比は、10〜90%、さらに好ましくは、20
〜80%である。Duty比が10%より小さい場合や
90%より大きい場合は、電界に対する液体中のイオン
の応答性が悪くなり、作用する電磁気力が小さくなるの
で流動が弱くなる。Further, in the case of an applied voltage whose duty ratio can be changed like the rectangular wave voltage shown in FIG. 5C, the preferable duty ratio is 10 to 90%, more preferably, 20%.
~ 80%. When the duty ratio is smaller than 10% or larger than 90%, the responsiveness of ions in the liquid to the electric field becomes poor, and the applied electromagnetic force becomes small, so that the flow becomes weak.
【0041】また、その周波数及び振幅電圧値は前述の
電極の陽極酸化や液体の電気分解(気泡の発生、反応
等)の有無と関連があり、一般に周波数が低いほどまた
振幅電圧値が大きいほど陽極酸化や電気分解が生じやす
い。例えば、導電率が1mS/cm程度の電解質水溶液
の場合、好ましい周波数は100KHz以上、さらに好
ましくは1MHz以上である。また、好ましい振幅電圧
値は電極対間の距離や電極の形状や液体媒体の導電率に
より変化するが、電界値としておおむね104 〜106
V/mである。The frequency and amplitude voltage value are related to the presence or absence of the above-described anodic oxidation of the electrode and the electrolysis of liquid (generation of bubbles, reaction, etc.). In general, the lower the frequency and the larger the amplitude voltage value, the more. Anodizing and electrolysis are likely to occur. For example, in the case of an aqueous electrolyte solution having a conductivity of about 1 mS / cm, a preferable frequency is 100 KHz or more, more preferably 1 MHz or more. Also preferred amplitude voltage value changes by the conductivity of the distance and the electrode shape and the liquid medium between the electrode pair, but generally 10 4 to 10 as a field value 6
V / m.
【0042】本発明における液体媒体の流動の原理は不
明な点も多いが、電極対の一方を作用電極、他方を対向
電極として説明すると以下のように考えられる。Although there are many unclear points about the principle of the flow of the liquid medium in the present invention, it is considered as follows if one of the electrode pairs is described as a working electrode and the other as a counter electrode.
【0043】作用電極と対向電極間に電圧を印加する
と、これらの電極間に電界が生じる。この電界によって
液体媒体中のイオンが動き、この時、両電極間に電流が
流れる。これと同時に作用電極を流れる電流によって作
用電極の近傍に磁界が生じる。作用電極の近傍で電界に
より運動するイオンは、磁界から電磁気力(ローレンツ
力)を受ける。このローレンツ力が本発明における流動
のメカニズムと思われる。作用電極と対向電極間に印加
する電圧が交番電圧の場合、電界によるイオンの動きは
時間平均すると実質上ほとんどなく、電磁気力のみが作
用していることになる。When a voltage is applied between the working electrode and the counter electrode, an electric field is generated between these electrodes. The ions in the liquid medium move due to this electric field, and at this time, a current flows between both electrodes. At the same time, a magnetic field is generated near the working electrode by the current flowing through the working electrode. Ions moving by an electric field near the working electrode receive an electromagnetic force (Lorentz force) from a magnetic field. This Lorentz force seems to be the flow mechanism in the present invention. When the voltage applied between the working electrode and the counter electrode is an alternating voltage, the movement of ions due to the electric field is practically negligible when averaged over time, and only the electromagnetic force acts.
【0044】本発明の電極の構成としては、電界による
イオンの運動の大きさ(電流の大きさ)と、電極の近傍
の磁界の強さが大きいことが好ましい。In the configuration of the electrode of the present invention, it is preferable that the magnitude of the movement of the ions (the magnitude of the current) due to the electric field and the strength of the magnetic field near the electrode are large.
【0045】従って、電界と作用電極近傍磁界の大きさ
が共に大きくなるように、電極形状を作用電極に電界が
集中するような形状が好ましい。Therefore, it is preferable that the electrode is shaped so that the electric field is concentrated on the working electrode so that both the electric field and the magnetic field near the working electrode are large.
【0046】また、このような作用電極を用いることに
よって、磁界印加と電界印加を同時に、しかも簡単に行
うことができ、磁界印加の手段や電界印加用の手段を独
立に設ける必要がない。Also, by using such a working electrode, the application of a magnetic field and an electric field can be performed simultaneously and simply, and it is not necessary to provide a means for applying a magnetic field and a means for applying an electric field independently.
【0047】以下、本発明で使用される電極の構成例を
図面を用いて説明する。Hereinafter, a configuration example of the electrode used in the present invention will be described with reference to the drawings.
【0048】図1において、1は先端が円錐形状の作用
電極であり、4は対向電極である。これらの電極間に電
圧を印加すると、周辺のイオンが電界(電気力線3)に
沿って動き(図中i方向)、作用電極1に電流Iが流れ
る。この電流Iにより作用電極の円錐軸を中心として同
心円状に磁界2が形成される。この時、作用電極近傍の
イオンは、対向電極4間で形成される電界3から力を受
け運動しているので、磁界2から電磁気力Fを受け、そ
の方向はほぼ作用電極の先端の円錐面に沿った方向とな
る。この方向は、印加電圧の極性を逆にしても変わら
ず、また、イオンが正負どちらでも変わらない。In FIG. 1, 1 is a working electrode having a conical tip, and 4 is a counter electrode. When a voltage is applied between these electrodes, the surrounding ions move along the electric field (lines of electric force 3) (i direction in the figure), and a current I flows through the working electrode 1. This current I forms a magnetic field 2 concentrically about the conical axis of the working electrode. At this time, the ions in the vicinity of the working electrode are moving by receiving a force from the electric field 3 formed between the opposing electrodes 4, and thus receive an electromagnetic force F from the magnetic field 2, and the direction is almost the conical surface at the tip of the working electrode Along the direction. This direction does not change even if the polarity of the applied voltage is reversed, and does not change whether the ions are positive or negative.
【0049】また、図2で示されるように、図1で示し
た円錐形状の電極を2本対向させて電極対を構成するこ
ともできる。Also, as shown in FIG. 2, an electrode pair can be formed by facing two conical electrodes shown in FIG.
【0050】この場合、2本の電極が相互に作用電極1
と対向電極4の関係となっている。この電極間に電圧を
印加すると図2で矢印で示したような液体の流動が生じ
る。In this case, the two electrodes are mutually
And the counter electrode 4. When a voltage is applied between the electrodes, a liquid flows as shown by arrows in FIG.
【0051】このように、本発明の凝集反応方法では、
電極近傍の微小領域の液体媒体中のイオンに電磁気力を
作用させることにより液体媒体を撹拌するため、凝集反
応を促進させることができると共に、少量の液体(分散
媒,試料液等)を用いて簡単に凝集反応を行うことがで
きる。Thus, in the agglutination reaction method of the present invention,
The liquid medium is agitated by applying electromagnetic force to ions in the liquid medium in a minute area near the electrode, so that the aggregation reaction can be promoted and a small amount of liquid (dispersion medium, sample liquid, etc.) can be used. Aggregation reaction can be easily performed.
【0052】次に、本発明の凝集反応装置を図面を用い
て説明する。図3は、図2に示したような電極構成を有
する本発明の凝集反応装置の一構成例を示している。図
中、6,6’はガラス基板、7はスペーサー、10はこ
れらで構成される反応セルを示しており、8,8’は先
端が円錐形状を有する電極、9は液体注入部である。Next, the agglutination reaction device of the present invention will be described with reference to the drawings. FIG. 3 shows one configuration example of the agglutination reaction device of the present invention having the electrode configuration as shown in FIG. In the figure, 6 and 6 'are glass substrates, 7 is a spacer, 10 is a reaction cell composed of these, 8, 8' are electrodes having a conical tip, and 9 is a liquid injection part.
【0053】本装置において、被測定物質を含む試料液
と、試薬としての生体関連物質とを分散したイオン導電
性を有する液体媒体を液体注入部9に導入し、電極8,
8’間に電源手段(不図示)により交番電圧を印加す
る。この時、電極8,8’近傍の液体媒体には、図2に
示したような移動が生じ、その結果、液体媒体は撹拌さ
れ、凝集反応が促進される。また、電極間に印加する電
圧値や周波数を変化させることに撹拌の効率を変化さ
せ、凝集反応の反応速度を制御することができる。In the present apparatus, a liquid medium having ionic conductivity in which a sample liquid containing a substance to be measured and a biological substance as a reagent are dispersed is introduced into a liquid injection section 9, and electrodes 8 and
An alternating voltage is applied between 8 'by power supply means (not shown). At this time, the liquid medium in the vicinity of the electrodes 8, 8 'moves as shown in FIG. 2, and as a result, the liquid medium is agitated, and the agglutination reaction is promoted. Also, by changing the voltage value and frequency applied between the electrodes, the efficiency of stirring can be changed, and the reaction speed of the agglutination reaction can be controlled.
【0054】次に、上記本発明の凝集反応方法及び凝集
反応装置を用いた濃度測定方法及び濃度測定装置につい
て説明する。Next, a method and apparatus for measuring the concentration using the agglutination reaction method and agglutination reaction apparatus of the present invention will be described.
【0055】本発明の濃度測定方法においては、前記の
凝集反応により生ずる反応混合物の凝集の度合が検出さ
れる。その具体的な測定手法としては、凝集反応の進行
に伴って検出される出力の時間変化を測定する場合や、
凝集反応が完了した時の出力を測定する場合等が考えら
れる。また、既知試料について測定を行ない検量線を求
めておき、定量的な検査を行なうことも可能である。In the concentration measuring method of the present invention, the degree of agglutination of the reaction mixture generated by the agglutination reaction is detected. As a specific measuring method, when measuring the time change of the output detected with the progress of the agglutination reaction,
It is conceivable to measure the output when the agglutination reaction is completed. It is also possible to perform a quantitative test by measuring a known sample and obtaining a calibration curve.
【0056】この時、反応混合物の凝集の度合を検出す
る領域としては、前記反応セル内に配置された電極対間
の撹拌領域が好ましい。At this time, the region for detecting the degree of aggregation of the reaction mixture is preferably a stirring region between the electrode pairs disposed in the reaction cell.
【0057】また、電極間に印加する電圧値や周波数を
変化させて撹拌の効率を変化させながら測定することも
可能である。Further, it is also possible to perform measurement while changing the efficiency of stirring by changing the voltage value and frequency applied between the electrodes.
【0058】本発明の濃度測定装置において、上記反応
混合物中の凝集の度合を測定する手段としては、目視す
る他に例えば、反応セルの透過光強度や散乱光強度を測
定するといった光学的手段やインピーダンス測定などの
電気的手段が用いられる。光学的手段の場合、光源とし
てはハロゲンランプ、Xeランプ等の光源の他、He−
Neレーザー,半導体レーザー等のレーザー光源も利用
できる。また、受光素子としては光電子増幅管,フォト
ダイオード,フォトトランジスター等が用いることがで
き、その出力は必要に応じて演算増幅器等を用いて増幅
される。In the concentration measuring apparatus of the present invention, as means for measuring the degree of aggregation in the reaction mixture, optical means such as measuring the transmitted light intensity and scattered light intensity of the reaction cell may be used in addition to visual observation. Electrical means such as impedance measurement is used. In the case of optical means, a light source such as a halogen lamp, a Xe lamp, etc.
Laser light sources such as Ne lasers and semiconductor lasers can also be used. Further, as the light receiving element, a photoelectron amplifier tube, a photodiode, a phototransistor, or the like can be used, and the output is amplified using an operational amplifier or the like as necessary.
【0059】[0059]
【実施例】以下、本発明を実施例により詳細に説明す
る。DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described below in detail with reference to embodiments.
【0060】実施例1 ヒトCRP抗体を感作させたポリスチレンラテックス粒
子(粒径1.2μm:デンカ生研(株)製)のPBS分
散液(固形分1.2mg/ml)と、試料液としての標
準CRP血清(協和油化製)を5μg/mlの濃度とな
るように混合し、図3に示した構成の反応セルに1μl
注入した。 Example 1 A dispersion of polystyrene latex particles (particle size: 1.2 μm, manufactured by Denka Seiken Co., Ltd.) sensitized with human CRP antibody in PBS (solid content: 1.2 mg / ml) was used as a sample solution. Standard CRP serum (manufactured by Kyowa Yuka) was mixed to a concentration of 5 μg / ml, and 1 μl was added to the reaction cell having the structure shown in FIG.
Injected.
【0061】反応セルは、厚さ1mmの2枚のスライド
ガラス6,6’間にスペーサー7を挟持して、液体注入
部9(注入口250μm×500μm)を形成して構成
している。電極8,8’は先端が円錐形状の金−タング
ステンワイヤー(50μm径,先端径10μm以下)を
用い、これを反応セル内に先端間隔100μmで対向さ
せた。上記混合液を注入口より反応セル内に注入後、図
4に示されるような測定装置により、凝集状態を検出し
CRP濃度を測定した。The reaction cell is constituted by forming a liquid injection section 9 (injection port 250 μm × 500 μm) by sandwiching a spacer 7 between two slide glasses 6 and 6 ′ having a thickness of 1 mm. The electrodes 8, 8 'were gold-tungsten wires (50 μm in diameter, 10 μm or less in diameter) having a conical tip, and were opposed to each other in the reaction cell at a tip interval of 100 μm. After the mixture was injected into the reaction cell from the injection port, the aggregation state was detected and the CRP concentration was measured by a measuring device as shown in FIG.
【0062】図4で10は反応セル、11はハロゲンラ
ンプ、12,12’はレンズ、13はフォトダイオー
ド、14はヒーター付ステージ、15は高周波電源、1
6,16’は電極、17はピンホールである。In FIG. 4, 10 is a reaction cell, 11 is a halogen lamp, 12 and 12 'are lenses, 13 is a photodiode, 14 is a stage with a heater, 15 is a high frequency power source,
Reference numerals 6, 16 'denote electrodes, and reference numeral 17 denotes a pinhole.
【0063】本実施例では、反応セル中の混合液をヒー
ター14により37℃に保ち、この状態で高周波電源1
5により電極間に1MHz,±10Vの矩形波を印加し
て、電極間の混合液を100秒間撹拌した。この時、電
極間の混合液は、図4の反応セル中の矢印で示した方向
に流動し撹拌された。撹拌後、電極間の透過光強度を測
定し、その凝集状態を測定した。このデータと予め用意
された検量線データとを比較することにより、試料液中
のCRP濃度を測定することができた。In the present embodiment, the mixture in the reaction cell is maintained at 37 ° C. by the heater 14 and the high-frequency power source 1
5, a 1 MHz, ± 10 V rectangular wave was applied between the electrodes, and the liquid mixture between the electrodes was stirred for 100 seconds. At this time, the mixture between the electrodes flowed in the direction indicated by the arrow in the reaction cell of FIG. 4 and was stirred. After stirring, the transmitted light intensity between the electrodes was measured, and the state of aggregation was measured. By comparing this data with calibration curve data prepared in advance, the CRP concentration in the sample solution could be measured.
【0064】比較例1 実施例1で電極間に電界を印加しない以外は、同様にし
て測定を行なった。100秒後の混合液の凝集状態を検
出したが、凝集度合が小さく、予め用意した検量線から
はCRP濃度が低く見積られ、正確な値が得られなかっ
た。 Comparative Example 1 Measurement was performed in the same manner as in Example 1 except that no electric field was applied between the electrodes. After 100 seconds, the state of aggregation of the mixed solution was detected. However, the degree of aggregation was small, and the CRP concentration was estimated to be low from a calibration curve prepared in advance, and an accurate value could not be obtained.
【0065】[0065]
【発明の効果】以上説明したように、本発明によれば以
下の効果を奏する。 (1)被測定物質を含む試料液と、該物質と選択特異的
に結合する生体関連物質とをイオン導電性を有する液体
媒体に分散し、この液体媒体を電極対間に導入し、該電
極間に正側と負側に周期的に変動する交番電圧を印加す
ることにより液体媒体を撹拌する本発明の凝集反応方法
及び凝集反応装置は、電極近傍の微小領域の液体媒体中
のイオンに電磁気力を作用させることにより液体媒体を
撹拌するため、凝集反応を促進させることができ、より
短時間で、しかも少量の液体(分散媒,試料液等)を用
いてより小型の装置で簡単に凝集反応を行うことができ
る。 (2)上記本発明の凝集反応方法及び装置を用いた本発
明の濃度測定方法及び装置は、上記試料液中の物質の濃
度を、より短時間で正確に測定することができる。As described above, according to the present invention, the following effects can be obtained. (1) A sample liquid containing a substance to be measured and a biological substance that selectively binds to the substance are dispersed in a liquid medium having ionic conductivity, and the liquid medium is introduced between an electrode pair. The agglutination reaction method and the agglutination reaction device of the present invention, which stirs the liquid medium by applying an alternating voltage that periodically fluctuates between the positive side and the negative side between Agglomeration reaction can be promoted because the liquid medium is agitated by applying force, and can be easily agglomerated in a shorter time and with a smaller device using a small amount of liquid (dispersion medium, sample liquid, etc.). The reaction can be performed. (2) The concentration measuring method and apparatus of the present invention using the agglutination reaction method and apparatus of the present invention can accurately measure the concentration of a substance in the sample solution in a shorter time.
【図1】本発明に用いることができる電極の構成例及び
液体媒体の撹拌の原理を説明するための図である。FIG. 1 is a diagram for explaining a configuration example of an electrode that can be used in the present invention and a principle of stirring a liquid medium.
【図2】本発明に用いることができる電極の他の構成例
を示す図である。FIG. 2 is a diagram showing another configuration example of an electrode that can be used in the present invention.
【図3】本発明の実施例で用いた凝集反応装置の概略構
成図である。FIG. 3 is a schematic configuration diagram of an agglutination reaction device used in an example of the present invention.
【図4】本発明の実施例で用いた濃度測定装置の概略構
成図である。FIG. 4 is a schematic configuration diagram of a concentration measuring device used in an embodiment of the present invention.
【図5】周期的に変動する電圧波形の例である。FIG. 5 is an example of a periodically varying voltage waveform.
1 作用電極 2 磁界 3 電気力線 4 対向電極 6,6’ ガラス基板 7 スペーサー 8,8’ 金−タングステンワイヤー電極 9 液体注入部 10 反応セル 11 ハロゲンランプ 12,12’ レンズ 13 フォトダイオード 14 ヒーター付ステージ 15 高周波電源 16,16’ 電極 17 ピンホール DESCRIPTION OF SYMBOLS 1 Working electrode 2 Magnetic field 3 Electric force line 4 Counter electrode 6,6 'Glass substrate 7 Spacer 8,8' Gold-tungsten wire electrode 9 Liquid injection part 10 Reaction cell 11 Halogen lamp 12,12 'Lens 13 Photodiode 14 With heater Stage 15 High frequency power supply 16, 16 'Electrode 17 Pinhole
───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.7,DB名) G01N 33/50 - 33/98 G01N 21/82 G01N 27/28 ──────────────────────────────────────────────────続 き Continued on front page (58) Field surveyed (Int.Cl. 7 , DB name) G01N 33/50-33/98 G01N 21/82 G01N 27/28
Claims (7)
に結合する生体関連物質とを、イオン導電性を有する液
体媒体中で凝集反応させる方法であって、 電極対の間に上記試料液と上記生体関連物質とを分散さ
せたイオン導電性を有する液体媒体を導入し、 上記電極対間に正側と負側に周期的に変動する交番電圧
を印加して、上記液体媒体を攪拌することを特徴とする
凝集反応方法。1. A method of causing an agglutination reaction between a substance in a sample solution and a biologically-related substance that selectively binds to the substance in a liquid medium having ionic conductivity, wherein the method comprises the steps of: A liquid medium having ionic conductivity in which a sample liquid and the biological substance are dispersed is introduced, and an alternating voltage that periodically fluctuates between the electrode pair on the positive side and the negative side is applied. An agglutination reaction method characterized by stirring.
持されていることを特徴とする請求項1記載の凝集反応
方法。2. The agglutination reaction method according to claim 1, wherein the biological substance is carried on the surface of fine particles.
施する装置であって、 前記電極対を少なくとも1組以上設けた反応セルと、 該電極対間に正側と負側に周期的に変動する交番電圧を
印加する電源手段を具備することを特徴とする凝集反応
装置。3. An apparatus for performing the agglutination reaction method according to claim 1 or 2 , wherein the reaction cell includes at least one pair of the electrode pairs , and a pair of the positive electrode and the negative electrode periodic between the pair of electrodes . An agglutination reaction device comprising a power supply means for applying an alternating voltage that fluctuates.
り生ずる反応混合物の凝集の度合を検出して、前記試料
液中の物質の濃度を測定することを特徴とする濃度測定
方法。4. A detecting a degree of aggregation of claim 1 or 2 the reaction mixture resulting from the agglutination method described, concentration measuring method and measuring the concentration of a substance in the sample liquid.
前記電極対間の反応混合物の凝集の度合を検出すること
を特徴とする濃度測定方法。5. The method according to claim 4 , wherein
A concentration measuring method, comprising detecting a degree of aggregation of a reaction mixture between the electrode pairs.
施する装置であって、 前記電極対を少なくとも1組以上設けた反応セルと、 該電極対間に正側と負側に周期的に変動する交番電圧を
印加する電源手段と、 上記反応セル内の反応混合物の凝集の度合を検出する検
出手段を具備することを特徴とする濃度測定装置。6. An apparatus for performing the concentration measuring method according to claim 4 or 5 , wherein a reaction cell having at least one pair of the electrode pairs is provided, and a positive electrode and a negative electrode are periodically arranged between the electrode pairs. A power supply means for applying a fluctuating alternating voltage; and a detecting means for detecting the degree of aggregation of the reaction mixture in the reaction cell.
ることを特徴とする請求項6記載の濃度測定装置。7. The concentration measuring apparatus according to claim 6 , wherein said detecting means is an optical detecting means.
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP33490592A JP3342065B2 (en) | 1992-11-24 | 1992-11-24 | Agglutination reaction method and agglutination reaction device, and concentration measurement method and concentration measurement device |
| EP93117397A EP0595290B1 (en) | 1992-10-27 | 1993-10-27 | Method for driving liquid |
| AT93117397T ATE156312T1 (en) | 1992-10-27 | 1993-10-27 | METHOD FOR PUMPING LIQUIDS |
| DE69312628T DE69312628T2 (en) | 1992-10-27 | 1993-10-27 | Process for conveying liquids |
| US08/926,009 US5788819A (en) | 1992-10-27 | 1997-09-09 | Method for driving liquid, and method and apparatus for mixing and agitation employing the method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP33490592A JP3342065B2 (en) | 1992-11-24 | 1992-11-24 | Agglutination reaction method and agglutination reaction device, and concentration measurement method and concentration measurement device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH06160285A JPH06160285A (en) | 1994-06-07 |
| JP3342065B2 true JP3342065B2 (en) | 2002-11-05 |
Family
ID=18282555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP33490592A Expired - Fee Related JP3342065B2 (en) | 1992-10-27 | 1992-11-24 | Agglutination reaction method and agglutination reaction device, and concentration measurement method and concentration measurement device |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3342065B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6684545B2 (en) * | 2015-04-22 | 2020-04-22 | オーソ・クリニカル・ダイアグノスティックス株式会社 | Detection or quantification method, resonant additive, method of using resonant structure and container |
| JP6876764B2 (en) * | 2019-09-24 | 2021-05-26 | オーソ・クリニカル・ダイアグノスティックス株式会社 | Detection or quantification method, resonant additive, resonant structure usage and container |
-
1992
- 1992-11-24 JP JP33490592A patent/JP3342065B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH06160285A (en) | 1994-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0595290B1 (en) | Method for driving liquid | |
| US7198702B1 (en) | Method for separating substances using dielectrophoretic forces | |
| JP4470310B2 (en) | Method for separating substances using dielectrophoretic force | |
| EP4075134A1 (en) | Method for detecting microproteins in sample system | |
| Song et al. | Multisample analysis using an array of microreactors for an alternating-current field-enhanced latex immunoassay | |
| EP0070527A1 (en) | Method of assaying biologically active substances and labelling agents therefor | |
| JP3342065B2 (en) | Agglutination reaction method and agglutination reaction device, and concentration measurement method and concentration measurement device | |
| JP3300493B2 (en) | Method for detecting or measuring the presence of a biologically specific reactive substance | |
| EP1930726A1 (en) | Method of assaying substance with affinity in sample including step of destroying blood-cell ingredient | |
| JP2008275523A (en) | Liquid sample analyzer | |
| US20070000311A1 (en) | Method for measuring substance having affinity | |
| JP4092374B2 (en) | Affinity substance measurement method | |
| US4792527A (en) | Method of assaying biologically active substances and labelling agents therefor | |
| JPH06201698A (en) | Trace substance detection method and detection device | |
| JPH0472567A (en) | Method and device for measuring immunologically active material | |
| JPH03186761A (en) | Dry type immunoassay analysis element containing signal dispersed bead | |
| WO2005088309A1 (en) | Method of measuring affinity substance | |
| EP1930725A1 (en) | Method of assaying substance with affinity in sample containing blood-cell ingredient | |
| JPH04344465A (en) | immunoassay | |
| JP2005308620A (en) | Method for measuring affinity substances by particle aggregation and dilution | |
| JP2007316081A (en) | Affinity substance measurement method | |
| KR20070018906A (en) | Method of measuring affinity substance | |
| JPH09101307A (en) | Method for detecting or measuring immunologically reactive substance | |
| JP2002243696A (en) | Highly sensitive analysis of trace proteins | |
| Tamiya | Pulse Immunoassay and Pulse Electrovoltage for Cell Manipulation and Analytical Coagulation Processes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20020730 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070823 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080823 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080823 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090823 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090823 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100823 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110823 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120823 Year of fee payment: 10 |
|
| LAPS | Cancellation because of no payment of annual fees |